Haemonetics Corp (HAE)
85.55
+0.12
(+0.14%)
USD |
NYSE |
Nov 22, 16:00
83.01
-2.54
(-2.97%)
Pre-Market: 20:00
Haemonetics Free Cash Flow: 20.35M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 20.35M |
| June 30, 2024 | 70.97M |
| March 31, 2024 | 115.46M |
| December 31, 2023 | 128.75M |
| September 30, 2023 | 216.68M |
| June 30, 2023 | 177.75M |
| March 31, 2023 | 162.87M |
| December 31, 2022 | 128.11M |
| September 30, 2022 | 116.31M |
| June 30, 2022 | 87.88M |
| March 31, 2022 | 75.75M |
| December 31, 2021 | 32.73M |
| September 30, 2021 | 53.88M |
| June 30, 2021 | 52.05M |
| March 31, 2021 | 71.76M |
| December 31, 2020 | 117.61M |
| September 30, 2020 | 119.58M |
| June 30, 2020 | 119.20M |
| March 31, 2020 | 109.46M |
| December 31, 2019 | 80.62M |
| September 30, 2019 | 50.65M |
| June 30, 2019 | 39.09M |
| March 31, 2019 | 40.32M |
| December 31, 2018 | 71.92M |
| September 30, 2018 | 81.82M |
| Date | Value |
|---|---|
| June 30, 2018 | 116.46M |
| March 31, 2018 | 145.55M |
| December 31, 2017 | 125.99M |
| September 30, 2017 | 123.47M |
| June 30, 2017 | 100.09M |
| March 31, 2017 | 83.60M |
| December 31, 2016 | 89.36M |
| September 30, 2016 | 61.16M |
| June 30, 2016 | 42.67M |
| March 31, 2016 | 19.46M |
| December 31, 2015 | 28.36M |
| September 30, 2015 | 17.48M |
| June 30, 2015 | 13.31M |
| March 31, 2015 | 4.958M |
| December 31, 2014 | -7.113M |
| September 30, 2014 | 25.42M |
| June 30, 2014 | 42.22M |
| March 31, 2014 | 65.88M |
| December 31, 2013 | 59.37M |
| September 30, 2013 | 38.31M |
| June 30, 2013 | 31.08M |
| March 31, 2013 | 22.89M |
| December 31, 2012 | 25.58M |
| September 30, 2012 | 32.56M |
| June 30, 2012 | 38.90M |
Free Cash Flow Range, Past 5 Years
20.35M
Minimum
Sep 2024
216.68M
Maximum
Sep 2023
102.89M
Average
112.46M
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Globus Medical Inc | 293.77M |
| ResMed Inc | 1.347B |
| Baxter International Inc | 391.00M |
| Integra Lifesciences Holdings Corp | 38.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 48.82M |
| Cash from Investing (Quarterly) | -23.37M |
| Cash from Financing (Quarterly) | -74.80M |
| Free Cash Flow Per Share (Quarterly) | 0.7687 |
| Free Cash Flow to Equity (Quarterly) | 38.02M |
| Free Cash Flow to Firm (Quarterly) | 44.68M |
| Free Cash Flow Yield | 0.46% |